Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy

ConclusionAnalysis of ECG intervals and concentration-QTc relationships showed a small but clinically insignificant effect of daratumumab.Trial RegistrationClinicalTrials.gov Identifier: NCT02316106.

http://link.springer.com/10.1007/s12325-020-01601-w

Source: Advances in Therapy - January 20, 2021 Category: Drugs & Pharmacology Source Type: research